We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
LINCOLN.NSE

Price
552.60
Stock movement up
+16.35 (3.05%)
Company name
Lincoln Pharmaceuticals Limited
Exchange
(NSE
,
Currency
INR
)
Sector
Healthcare >
Drug Manufacturers - Specialty & Generic
Market cap
11.07B
Ent value
12.37B
Price/Sales
1.85
Price/Book
1.73
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
11.45
Forward P/E
-
PEG
-
EPS growth
13.85%
1 year return
-9.20%
3 year return
20.51%
5 year return
37.25%
10 year return
-
Last updated: 2025-04-12

DIVIDENDS

LINCOLN.NSE does not pay dividends or no data was received

VALUATION

Valuation Ratios

Valuation Ratios data
Trailing P/E11.45
Price to OCF196.68
Price to FCF196.68
Price to EBITDA37.32
EV to EBITDA41.71

Valuation (Sales/Book Value)

Valuation (Sales/Book Value) data
Price to Sales1.85
Price to Book1.73
EV to Sales2.07

FINANCIALS

Per share

Per share data
Current share count20.03M
EPS (TTM)48.26
FCF per share (TTM)2.81

Income statement

Income statement data
Revenue (TTM)5.97B
Gross profit (TTM)2.25B
Operating income (TTM)905.68M
Net income (TTM)966.39M
EPS (TTM)48.26
EPS (1y forward)-

Margins

Margins data
Gross margin (TTM)37.66%
Operating margin (TTM)15.16%
Profit margin (TTM)16.18%

Balance Sheet

Please create a free account or log in to access this chart
Balance Sheet data
Cash101.35M
Net receivables0.00
Total current assets5.23B
Goodwill0.00
Intangible assets3.21M
Property, plant and equipment0.00
Total assets7.80B
Accounts payable950.87M
Short/Current long term debt13.55M
Total current liabilities1.20B
Total liabilities1.41B
Shareholder's equity6.39B
Net tangible assets0.00

Cash flow

Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)56.28M
Capital expenditures (TTM)0.00
Free cash flow (TTM)56.28M
Dividends paid (TTM)0.00

Financial returns

Please create a free account or log in to access this chart
Financial returns data
Return on Equity15.12%
Return on Assets12.39%
Return on Invested Capital15.09%
Cash Return on Invested Capital0.88%

STOCK INFORMATION

Stock chart

Stock price data
Open546.45
Daily high557.00
Daily low544.00
Daily Volume29K
All-time high953.70
1y analyst estimate-
Beta0.68
EPS (TTM)48.26
Dividend per share-
Ex-div date13 Sep 2024
Next earnings date14 May 2025

Downside potential

Downside potential data
LINCOLN.NSES&P500
Current price drop from All-time high-42.06%-12.89%
Highest price drop-70.05%-56.47%
Date of highest drop23 Mar 20209 Mar 2009
Avg drop from high-25.29%-11.07%
Avg time to new high42 days12 days
Max time to new high661 days1805 days
COMPANY DETAILS
LINCOLN.NSE (Lincoln Pharmaceuticals Limited) company logo
Marketcap
11.07B
Marketcap category
Large-cap
Description
Lincoln Pharmaceuticals Limited engages in manufacturing and trading of pharmaceutical products in India. The company offers products in the areas of anticold, antibiotic, otolaryngology, pain management, gastro, anti-malarial, anti-fungal, corticosteroids and cosmo-derma, anti-diabetic, anti-hypertensive, gynecology, cardio and CNS, respiratory system, and dyslipidemic; and branded generics. It also exports its products to approximately 60 countries, including Europe, Canada, Latin and North America, Africa, the Asia Pacific, and South East Asia. The company was incorporated in 1979 and is based in Ahmedabad, India.
Employees
1687
Website
https://www.lincolnpharma.com
Investor relations
-
SEC filings
LINCOLN.NSE SEC filings
CEO
Country
India
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
UNDERSTAND THE BUSINESS
COMPANY NEWS
All newsPress releases
No items found
Disclaimer
Skyfall Technology OÜ assumes no responsibility or liability for any errors or omissions in the content of this site. The information contained in this site is provided on an “as is” basis with no guarantees of completeness, accuracy, usefulness or timeliness. Please also note, that any action you take upon the information provided on this website is strictly at your own risk. This website is intended to be used and must be used for informational purposes only and you should take independent financial advice from a professional and independently research and verify everything you see on the site.
Menu
HomePortfolio ManagementCompany ScreenerGreen InvestmentExchangesContact Us
Language
ENHUNOSVDAFIESDENLFRITPTPLCSSKROELTRRUAF
© 2024 Skyfall Technology OÜ All Rights Reserved